
Ashland (ASH) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
479.0M
Gross Profit
147.0M
30.69%
Operating Income
33.0M
6.89%
Net Income
31.0M
6.47%
EPS (Diluted)
$0.65
Balance Sheet Metrics
Total Assets
5.2B
Total Liabilities
2.7B
Shareholders Equity
2.6B
Debt to Equity
1.04
Cash Flow Metrics
Operating Cash Flow
93.0M
Free Cash Flow
-20.0M
Revenue & Profitability Trend
Ashland Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 2.1B | 2.2B | 2.4B | 2.1B | 2.0B |
Cost of Goods Sold | 1.5B | 1.5B | 1.6B | 1.4B | 1.4B |
Gross Profit | 618.0M | 668.0M | 830.0M | 670.0M | 599.0M |
Gross Margin % | 29.2% | 30.5% | 34.7% | 31.7% | 29.7% |
Operating Expenses | |||||
Research & Development | 55.0M | 51.0M | 55.0M | 50.0M | 56.0M |
Selling, General & Administrative | 404.0M | 365.0M | 393.0M | 358.0M | 400.0M |
Other Operating Expenses | - | - | - | - | -8.0M |
Total Operating Expenses | 459.0M | 416.0M | 448.0M | 408.0M | 448.0M |
Operating Income | 83.0M | 159.0M | 288.0M | 172.0M | 59.0M |
Operating Margin % | 3.9% | 7.3% | 12.0% | 8.1% | 2.9% |
Non-Operating Items | |||||
Interest Income | 10.0M | 12.0M | 4.0M | 1.0M | 1.0M |
Interest Expense | 53.0M | 54.0M | 62.0M | 69.0M | 88.0M |
Other Non-Operating Income | -62.0M | 46.0M | -20.0M | 51.0M | -487.0M |
Pre-tax Income | -24.0M | 160.0M | 206.0M | 135.0M | -577.0M |
Income Tax | -223.0M | -8.0M | 25.0M | -38.0M | -22.0M |
Effective Tax Rate % | 0.0% | -5.0% | 12.1% | -28.1% | 0.0% |
Net Income | 169.0M | 178.0M | 927.0M | 220.0M | -508.0M |
Net Margin % | 8.0% | 8.1% | 38.8% | 10.4% | -25.2% |
Key Metrics | |||||
EBITDA | 343.0M | 409.0M | 553.0M | 404.0M | 244.0M |
EPS (Basic) | $3.40 | $3.36 | $17.17 | $3.86 | $-8.33 |
EPS (Diluted) | $3.36 | $3.31 | $16.41 | $3.59 | $-8.39 |
Basic Shares Outstanding | 49000000 | 53000000 | 54000000 | 57000000 | 61000000 |
Diluted Shares Outstanding | 49000000 | 53000000 | 54000000 | 57000000 | 61000000 |
Income Statement Trend
Ashland Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 300.0M | 417.0M | 646.0M | 210.0M | 454.0M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 243.0M | 338.0M | 402.0M | 369.0M | 437.0M |
Inventory | 545.0M | 626.0M | 629.0M | 473.0M | 506.0M |
Other Current Assets | 107.0M | 125.0M | 91.0M | 68.0M | 87.0M |
Total Current Assets | 1.2B | 1.5B | 1.8B | 1.7B | 1.5B |
Non-Current Assets | |||||
Property, Plant & Equipment | 114.0M | 122.0M | 107.0M | 124.0M | 126.0M |
Goodwill | 3.5B | 3.6B | 3.6B | 4.0B | 3.6B |
Intangible Assets | 757.0M | 892.0M | 969.0M | 1.1B | 1.0B |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 874.0M | 664.0M | 695.0M | 776.0M | 1.4B |
Total Non-Current Assets | 4.4B | 4.4B | 4.4B | 4.9B | 5.3B |
Total Assets | 5.6B | 5.9B | 6.2B | 6.6B | 6.9B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 214.0M | 210.0M | 265.0M | 236.0M | 211.0M |
Short-term Debt | 20.0M | 38.0M | 19.0M | 397.0M | 302.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | 50.0M | 28.0M |
Total Current Liabilities | 490.0M | 456.0M | 553.0M | 934.0M | 813.0M |
Non-Current Liabilities | |||||
Long-term Debt | 1.4B | 1.4B | 1.4B | 1.7B | 1.7B |
Deferred Tax Liabilities | 29.0M | 148.0M | 176.0M | 237.0M | 229.0M |
Other Non-Current Liabilities | 25.0M | 22.0M | 16.0M | 21.0M | 36.0M |
Total Non-Current Liabilities | 2.3B | 2.4B | 2.4B | 2.9B | 3.0B |
Total Liabilities | 2.8B | 2.8B | 3.0B | 3.9B | 3.8B |
Equity | |||||
Common Stock | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
Retained Earnings | 3.3B | 3.6B | 3.7B | 2.8B | 2.6B |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 2.9B | 3.1B | 3.2B | 2.8B | 3.0B |
Key Metrics | |||||
Total Debt | 1.5B | 1.5B | 1.4B | 2.1B | 2.0B |
Working Capital | 705.0M | 1.0B | 1.2B | 783.0M | 734.0M |
Balance Sheet Composition
Ashland Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 199.0M | 168.0M | 181.0M | 173.0M | -508.0M |
Depreciation & Amortization | 274.0M | 243.0M | 241.0M | 244.0M | 235.0M |
Stock-Based Compensation | 15.0M | 22.0M | 18.0M | 15.0M | 14.0M |
Working Capital Changes | 171.0M | 54.0M | -271.0M | 77.0M | 55.0M |
Operating Cash Flow | 348.0M | 453.0M | 136.0M | 482.0M | -287.0M |
Investing Activities | |||||
Capital Expenditures | -137.0M | -159.0M | -62.0M | -100.0M | -128.0M |
Acquisitions | 26.0M | 0 | 0 | -295.0M | 9.0M |
Investment Purchases | -53.0M | -47.0M | -87.0M | -149.0M | -21.0M |
Investment Sales | 53.0M | 47.0M | 87.0M | 150.0M | 21.0M |
Investing Cash Flow | -51.0M | -109.0M | -102.0M | -367.0M | -85.0M |
Financing Activities | |||||
Share Repurchases | -380.0M | -300.0M | -200.0M | -450.0M | 0 |
Dividends Paid | -78.0M | -76.0M | -70.0M | -70.0M | -66.0M |
Debt Issuance | - | 0 | 0 | 450.0M | 804.0M |
Debt Repayment | 0 | 0 | -250.0M | -427.0M | -826.0M |
Financing Cash Flow | -479.0M | -371.0M | -896.0M | -426.0M | 9.0M |
Free Cash Flow | 274.0M | 73.0M | -326.0M | 455.0M | 70.0M |
Net Change in Cash | -182.0M | -27.0M | -862.0M | -311.0M | -363.0M |
Cash Flow Trend
Ashland Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
18.02
Forward P/E
9.34
Price to Book
1.30
Price to Sales
1.31
PEG Ratio
0.00
Profitability Ratios
Profit Margin
-46.07%
Operating Margin
7.34%
Return on Equity
-34.43%
Return on Assets
1.78%
Financial Health
Current Ratio
2.68
Debt to Equity
78.61
Beta
0.48
Per Share Data
EPS (TTM)
$-17.97
Book Value per Share
$41.33
Revenue per Share
$39.98
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
ash | 2.4B | 18.02 | 1.30 | -34.43% | -46.07% | 78.61 |
Linde plc | 222.6B | 34.37 | 5.86 | 17.01% | 20.02% | 60.56 |
Sherwin-Williams | 91.5B | 36.39 | 20.70 | 62.43% | 11.03% | 308.57 |
Albemarle | 9.9B | 33.52 | 1.26 | -9.99% | -22.39% | 35.76 |
Eastman Chemical | 7.6B | 9.29 | 1.30 | 14.39% | 8.96% | 90.60 |
NewMarket | 7.4B | 15.62 | 4.60 | 33.74% | 17.28% | 56.98 |
Financial data is updated regularly. All figures are in the company's reporting currency.